Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed this 8-K on January 27, 2021, to report its financial results for the quarter ended December 31, 2020. The primary purpose of the filing is to furnish a press release detailing these results, which are incorporated by reference. This report primarily serves to disseminate timely financial information to investors and the market. Investors should note that the information furnished in this filing is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it automatically incorporated into future SEC filings unless specifically referenced. The document also includes standard forward-looking statements, cautioning investors about risks and uncertainties that could materially affect actual results, including potential impacts from the COVID-19 pandemic, regulatory changes, healthcare costs, and competitive pressures.
Key Highlights
- 1The 8-K filing primarily serves to announce and provide access to the company's financial results for the fourth quarter of 2020, released on January 27, 2021.
- 2The press release containing the detailed financial results for the quarter ended December 31, 2020, is furnished as Exhibit 99.1.
- 3The filing includes standard cautionary language regarding forward-looking statements, highlighting potential risks and uncertainties.
- 4Key risks and uncertainties mentioned include the impact of public health emergencies (like COVID-19), healthcare cost trends, regulatory changes (including the ACA), and competitive pressures.
- 5The company is identified as Anthem, Inc. in this filing, indicating the name change to Elevance Health, Inc. was likely subsequent or this filing predates the official name change announcement.
- 6No new material events or business updates beyond the financial results announcement are detailed in the 8-K itself.